The goal of transplantation in patients with XIAP deficiency is to establish sufficient donor cell engraftment to prevent HLH recurrence; however, there is no consensus regarding the lowest level of donor chimerism required to prevent disease relapse following HSCT. Here, XIAP is linked to hemophagocytic syndrome.